New Clinical Trials for Ovarian Cancer Offered by the Oncology Institute of Hope and Innovation

The Oncology Institute of Hope and Innovation is proud to have access to the latest research, technology and treatment options, including clinical trials for eligible patients with ovarian cancer.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Downey, California (PRWEB) September 07, 2012

The Oncology Institute of Hope and Innovation is proud to have access to the latest research, technology and treatment options, including clinical trials for eligible patients. It is dedicated to providing comprehensive medical services to our patients. In its quest to be at the forefront of the latest medical cancer research, it participates in numerous clinical trials focused on various types of malignancies that may be of interest to oncology patients. It is pleased to make the announcement of the following clinical trial for individuals with advanced ovarian cancer which may benefit some patients:

A Randomized, Open-Label Crossover Study of Bioequivalence and Safety of Doxorubicin Hydrochloride Liposome Injection Formulations in Patients with Advanced Carcinoma of the Ovary

The primary objective is to assess the bioequivalence of two doxorubicin hydrochloride liposome injection formulations, TLC-Doxo 2 mg/ml as test product and Caelyx 2 mg/ml as the Reference Drug, by conducting a pharmacokinetic analysis.

If you have patients who you feel may qualify for this trial, or have questions regarding eligibility, you may contact any one of the offices listed on their website to schedule an evaluation.

About The Oncology Institute:
The Oncology Institute of Hope and Innovation is committed to providing superior, compassionate and state-of-the-art medical care. Offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. Dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, The Oncology Institute of Hope and Innovation has 9 Southern California locations in the cities of Anaheim, Downey, Glendale, Long Beach, Lynwood, Montebello, Torrance, Santa Ana, and Whittier. For more information please visit http://www.theoncologyinstitute.com.


Contact